“We are developing innovative stem cell-based therapeutics to treat severe life-threatening diseases, where effective treatment is lacking or is insufficient”

About Amniotics by CEO Kåre Engkilde

Our mission is to develop the very best stem cell-based therapeutics that give hope for patients and their relatives

Unique Technology

Amniotic's platform enables the extraction of Mesenchymal Stem Cells (MSC) from amniotic fluid, which is recovered from healthy voluntary donors in connection with planned caesarean sections

Read more

Pipeline

Amniotics has a project portfolio where the same technology and methodology can be applied for various indications

Read more

Donors

Our procedure for collecting term amniotic fluid from voluntary healthy donors is performed at full-term planned caesarean deliveries

Read more

Collaborate with us

Read more

Use our GMP facility

Amniotics is a technology and service provider to Universities, Hospitals, and the Biopharmaceutical industry.

Advance our pipeline

Amniotics is looking to establish strategic partnerships with researchers and companies to accelerate the development of our stem-cell-based therapies to the benefit of patients. See our pipeline here.